Stayble appoints Mangold as Liquidity Provider
March 2020Stayble Therapeutics AB (”Stayble” or the “Company”) has appointed Mangold Fondkommission as liquidity provider for the Company’s share on Nasdaq First North Growth Market with first day of trading March 9.
A liquidity provider’s aim is to improve the liquidity of a share and reduce the spread between the bidding and asking price. Mangold Fondkommission’s assignment commences on the first day of trading March 9, 2020.
Mangold will fulfill its assignment as liquidity provider to ensure the possibility of trading in Stayble’s share every day by continuously placing trading records on each purchase and sales page in the order book. A liquidity provider aims to create a more accurate pricing of a company’s share, which in turn gives a more accurate valuation of the company and allows for an improved trading volume in the share.
For more information
Andreas Gerward, CEO Stayble Therapeutics AB
andreas.gerward@stayble.se
+46 730 808 397